Credit Suisse’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $19.3M | Sell |
129,346
-46,630
| -26% | -$6.97M | 0.02% | 639 |
|
2023
Q4 | $33.7M | Buy |
175,976
+10,564
| +6% | +$2.02M | 0.03% | 498 |
|
2023
Q3 | $29.3M | Sell |
165,412
-2,724
| -2% | -$482K | 0.03% | 526 |
|
2023
Q2 | $31.9M | Buy |
168,136
+36,063
| +27% | +$6.85M | 0.03% | 523 |
|
2023
Q1 | $26.5M | Buy |
132,073
+5,994
| +5% | +$1.2M | 0.03% | 578 |
|
2022
Q4 | $30M | Buy |
126,079
+12,570
| +11% | +$2.99M | 0.03% | 550 |
|
2022
Q3 | $22.7M | Sell |
113,509
-1,184
| -1% | -$237K | 0.03% | 612 |
|
2022
Q2 | $16.7M | Sell |
114,693
-4,917
| -4% | -$717K | 0.02% | 742 |
|
2022
Q1 | $19.5M | Buy |
119,610
+6,071
| +5% | +$991K | 0.02% | 774 |
|
2021
Q4 | $19.3M | Sell |
113,539
-44,147
| -28% | -$7.49M | 0.01% | 810 |
|
2021
Q3 | $29.8M | Sell |
157,686
-27,625
| -15% | -$5.22M | 0.02% | 657 |
|
2021
Q2 | $31.4M | Sell |
185,311
-41,886
| -18% | -$7.1M | 0.02% | 668 |
|
2021
Q1 | $32.1M | Buy |
227,197
+52,963
| +30% | +$7.48M | 0.02% | 677 |
|
2020
Q4 | $22.6M | Buy |
174,234
+12,820
| +8% | +$1.67M | 0.01% | 781 |
|
2020
Q3 | $23.5M | Sell |
161,414
-5,828
| -3% | -$849K | 0.01% | 692 |
|
2020
Q2 | $24.8M | Sell |
167,242
-42,555
| -20% | -$6.3M | 0.02% | 653 |
|
2020
Q1 | $22.8M | Buy |
209,797
+35,051
| +20% | +$3.82M | 0.02% | 613 |
|
2019
Q4 | $20.1M | Sell |
174,746
-17,896
| -9% | -$2.06M | 0.01% | 764 |
|
2019
Q3 | $15.5M | Sell |
192,642
-99,736
| -34% | -$8.02M | 0.01% | 805 |
|
2019
Q2 | $21.2M | Buy |
292,378
+10,046
| +4% | +$729K | 0.02% | 686 |
|
2019
Q1 | $26.4M | Sell |
282,332
-7,913
| -3% | -$739K | 0.02% | 559 |
|
2018
Q4 | $21.2M | Buy |
290,245
+42,054
| +17% | +$3.07M | 0.02% | 623 |
|
2018
Q3 | $21.7M | Buy |
248,191
+34,302
| +16% | +$3M | 0.02% | 693 |
|
2018
Q2 | $21.1M | Sell |
213,889
-98,641
| -32% | -$9.72M | 0.02% | 681 |
|
2018
Q1 | $37.2M | Buy |
312,530
+86,693
| +38% | +$10.3M | 0.03% | 472 |
|
2017
Q4 | $28.7M | Buy |
225,837
+66,911
| +42% | +$8.5M | 0.03% | 548 |
|
2017
Q3 | $18.7M | Sell |
158,926
-21,817
| -12% | -$2.56M | 0.02% | 700 |
|
2017
Q2 | $14.4M | Sell |
180,743
-67,621
| -27% | -$5.39M | 0.01% | 833 |
|
2017
Q1 | $12.7M | Buy |
248,364
+69,697
| +39% | +$3.57M | 0.01% | 925 |
|
2016
Q4 | $6.69M | Sell |
178,667
-40,003
| -18% | -$1.5M | 0.01% | 1247 |
|
2016
Q3 | $14.8M | Buy |
218,670
+9,375
| +4% | +$635K | 0.01% | 862 |
|
2016
Q2 | $11.6M | Sell |
209,295
-25,173
| -11% | -$1.4M | 0.01% | 946 |
|
2016
Q1 | $14.7M | Buy |
234,468
+44,957
| +24% | +$2.82M | 0.02% | 809 |
|
2015
Q4 | $17.8M | Sell |
189,511
-17,580
| -8% | -$1.66M | 0.02% | 784 |
|
2015
Q3 | $16.6M | Sell |
207,091
-102,839
| -33% | -$8.26M | 0.02% | 792 |
|
2015
Q2 | $37.2M | Buy |
309,930
+37,976
| +14% | +$4.55M | 0.04% | 506 |
|
2015
Q1 | $28.4M | Buy |
271,954
+22,482
| +9% | +$2.35M | 0.03% | 597 |
|
2014
Q4 | $24.2M | Buy |
249,472
+77,754
| +45% | +$7.54M | 0.02% | 677 |
|
2014
Q3 | $13.4M | Sell |
171,718
-24,846
| -13% | -$1.94M | 0.01% | 978 |
|
2014
Q2 | $12.4M | Buy |
196,564
+47,586
| +32% | +$3.01M | 0.01% | 1054 |
|
2014
Q1 | $10M | Buy |
148,978
+26,967
| +22% | +$1.81M | 0.01% | 1093 |
|
2013
Q4 | $7.85M | Buy |
122,011
+25,608
| +27% | +$1.65M | 0.01% | 1233 |
|
2013
Q3 | $6.17M | Sell |
96,403
-21,126
| -18% | -$1.35M | 0.01% | 1237 |
|
2013
Q2 | $3.64M | Buy |
+117,529
| New | +$3.64M | ﹤0.01% | 1565 |
|